|
FAM76B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.577800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.628000E-02 |
| Normal-vs-Stage2 |
2.130800E-01 |
| Normal-vs-Stage3 |
6.924000E-01 |
| Normal-vs-Stage4 |
8.180800E-01 |
| Stage1-vs-Stage2 |
5.616200E-01 |
| Stage1-vs-Stage3 |
1.392210E-01 |
| Stage1-vs-Stage4 |
6.066800E-01 |
| Stage2-vs-Stage3 |
1.685600E-01 |
| Stage2-vs-Stage4 |
4.639600E-01 |
| Stage3-vs-Stage4 |
6.387000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.274200E-02 |
| Normal-vs-AfricanAmerican |
1.026050E-01 |
| Normal-vs-Asian |
7.486000E-01 |
| Caucasian-vs-AfricanAmerican |
6.047200E-01 |
| Caucasian-vs-Asian |
7.525400E-01 |
| AfricanAmerican-vs-Asian |
6.769200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.397800E-02 |
| Normal-vs-Female |
8.575800E-02 |
| Male-vs-Female |
6.883200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.722810E-01 |
| Normal-vs-Extreme_Weight |
2.361800E-01 |
| Normal-vs-Obese |
7.865900E-02 |
| Normal-vs-Extreme_Obese |
6.166800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.097600E-01 |
| Normal_Weight-vs-Obese |
9.205200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.080600E-01 |
| Extreme_Weight-vs-Obese |
4.788400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.693000E-01 |
| Obese-vs-Extreme_Obese |
2.382600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.708300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.877500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.730400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.502800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.178200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.352200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.582300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.384200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.620100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.355400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.028500E-04 |
| Normal-VS-Type2 PRCC |
5.420000E-02 |
| Normal-VS-KIRP CIMP |
6.826200E-01 |
| Normal-VS-Unclassified PRCC |
2.609000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.53440002317973E-09 |
| Type1 PRCC-VS-KIRP CIMP |
3.290600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.195200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.108840E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.058300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.898200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.194800E-01 |
| Normal-vs-N1 |
5.669600E-01 |
| Normal-vs-N2 |
1.691570E-02 |
| N0-vs-N1 |
5.994800E-01 |
| N0-vs-N2 |
7.679600E-02 |
| N1-vs-N2 |
1.002370E-01 |
|
|
